Importantly, genetic alternations of XRN2, such as mutations, mRNA expression, and copy number variations, are common in a wide range of cancers; XRN2 polymorphisms contribute to an increased risk of spontaneous lung cancer [20,21,22,23]. Here, XRN2 is linked to lung carcinoma.